Wink Therapeutics Wins Seattle Pitch Event, Gains $50K-$100K Investment for RNA-Based Type 1 Diabetes Therapy

Wink Therapeutics, a Miami-based RNA biotech startup focused on Type 1 diabetes, won first place and $50,000-$100,000 investment at a Seattle pitch event hosted by Venture Black. The company uses RNA therapeutics to restore pancreatic beta cells and was founded by biotech veteran Warren Marcus.

JJesse Posey EEvan Poncelet VVenture Black